Time will tell, when the cooler fall and winter temps come...and with them increased rates of viral infection as typically happens....then I believe we'll have a better idea if the shots are safe and effective. There is a growing list of vaccine experts expressing concerns, the most recent being Byram Bridle, a viral immunologist and associate professor at University of Guelph who has been interviewed by Post Media here in Canada....he is particularily concerned about the risks to younger recepients (especially kids 12-18) being greater for the vaccine than the virus itself.  

As we wait for the longer term safety profile to be established, here's hoping that Apabetalone can prove effective...it'd be nice to have a treatment that doesn't carry the risk of deadly blood clots, heart inflamation and all the others being identified with the jabs.